Chelsea Camarda is a Brooklyn, New York based nurse practitioner. Active license number of Chelsea Camarda is 355405 for Family in New York. Her current practice location is 3500 Nostrand Ave, Brooklyn. Patients can reach her at 718-769-2521. Chelsea Camarda is FNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1104289354. Chelsea Camarda has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Chelsea Camarda speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1104289354
NPI Enumeration Date:
04 Apr, 2016
NPI Last Update On:
31 Mar, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chelsea Camarda are as mentioned below.
License Number
Specialization
State
Status
355405
Family
New York
Primary
706097
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Chelsea Camarda 3500 Nostrand Ave, Brooklyn, New York
Zip:
11229-5107
Phone Number:
718-769-2521
Patients can reach Chelsea Camarda at 3500 Nostrand Ave, Brooklyn, New York or can call to book an appointment on 718-769-2521.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.